Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop  Frontiers in Pharmacology. 2023;14:1289365
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38283835

AOTMiT reimbursement recommendations compared to other HTA agencies  European Journal of Health Economics. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38261131

Appraisal of Novel Oncological Therapies by the Scottish Medicines Consortium and the National Institute for Health and Care Excellence: A Comparative Study of Six Years of Data  Cureus. 2023;15(12):e50560
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38222244

Artificial Intelligence in Surgery: The Future is Now  European Surgical Research. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38253041

Availability and Coverage of New Drugs in 6 High-Income Countries With Health Technology Assessment Bodies  JAMA Internal Medicine. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38285561

Centering Equity in Cardiovascular Health Technology Assessment  Canadian Journal of Cardiology. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38253126

Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies - can alignment be improved?  Expert Review of Pharmacoeconomics & Outcomes Research. 2024;24(2):251-265
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37747280

Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance  Value in Health. 2024;27(2):265-267
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38135213

Examining how well economic evaluations capture the value of mental health  Lancet Psychiatry. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38281493

Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply  Health Research Policy and Systems. 2024;22(1):11
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38225573

Health technology assessment in India in the next decade: reflections on a vision for its path to maturity and impact  BMJ Evidence Based Medicine. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38290800

Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments  Journal of Comparative Effectiveness Research. 2024;13(2):e230140
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38174576

Mapping of health technology assessment in China: a comparative study between 2016 and 2021  Global Health Research and Policy. 2024;9(1):4
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38229176

Navigating the unknown: how to best 'reflect' standard of care in indications without a dedicated treatment pathway in health technology assessment submissions  Journal of Comparative Effectiveness Research. 2024;13(2):e230145
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38226913

RANZCR collaborates on how-to paper for developing, purchasing and monitoring AI  Pulse+IT. 2024
https://login.smhslibresources.health.wa.gov.au/login?url=https://www.pulseit.news/australian-digital-health/ranzcr-collaborates-on-how-to-paper-for-developing-purchasing-and-monitoring-ai/

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health  BMJ Evidence Based Medicine. 2024;29(1):1-5
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36788020

A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries  Applied Health Economics and Health Policy. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38214848

Robot-assisted surgery in thoracic and visceral indications: an updated systematic review  Surgical Endoscopy. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38307958

Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum  Pharmacoeconomics. 2024;42(2):137-144
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37991631

Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments  Pharmacoeconomics. 2024;42(2):165-176
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37891433

Twenty years of network meta-analysis: Continuing controversies and recent developments  Research Synthesis Methods. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38234221

Why Language Matters in Digital Endpoint Development: Harmonized Terminology as a Key Prerequisite for Evidence Generation  Digital Biomarkers. 2024;8(1):1-12
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38222479